Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting



Status:Completed
Conditions:HIV / AIDS, HIV / AIDS, HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - Any
Updated:10/13/2018
Start Date:January 30, 2014
End Date:June 1, 2018

Use our guide to learn which trials are right for you!

This study identifies social and behavioral factors likely to influence PrEP acceptability
and adherence among men who have sex with men (MSM), and collaborates with a community health
center to evaluate a two-stage intervention to improve PrEP decision-making, as well as
persistence and adherence for those who chose to take PrEP.

Pre-exposure prophylaxis (PrEP) refers to daily or intermittent oral administration of
antiretroviral drugs designed to protect high-risk HIV-negative individuals from infection.
In order for PrEP to become an effective prevention tool, three critical factors must be
addressed: a) acceptability, i.e., individuals who would benefit from PrEP must know about it
and be willing to take it; b) adherence, i.e., individuals who choose to PrEP as a prevention
strategy must take the pills as prescribed; and c) implementation, i.e., processes and
protocols must be developed to allow for the integration of PrEP delivery and programs into
real world settings in a way that is feasible, scalable, and realistic. This project has
three specific aims: 1) Identifying social and behavioral factors that are likely to
influence PrEP implementation, acceptance, and use/adherence by men who have sex with men
(MSM) in NYC, including factors at individual-, community-, and organizational-levels; 2)
Examining social and behavioral factors associated with disparities in access to prevention
and care services among MSM in NYC that might directly impact PrEP implementation programs
and policies; and 3) Evaluating an intervention in which PrEP is introduced, provided, and
supported as part of a prevention package delivered in an community health center. The
project has the potential to exert a sustained and powerful influence not only on the
effectiveness of PrEP interventions for MSM, but also on dissemination and scalability of a
targeted intervention within community-based settings and in a manner that reduces
disparities in access and maximizes cultural competence and acceptability.

Inclusion Criteria:

- Registered patient receiving medical or health services at Callen-Lorde Community
Health Center

- Male sex (at birth) and reported sex with men or transwomen

- At least 18 years of age

- HIV-negative

- At risk for HIV acquisition

Exclusion Criteria:

- Past history of PrEP use or currently taking PrEP
We found this trial at
1
site
New York, New York 10011
Principal Investigator: Anita Radix, MD
Phone: 212-271-7200
?
mi
from
New York, NY
Click here to add this to my saved trials